Trials / Conditions / Advanced Sarcomatoid Renal Cell Carcinoma
Advanced Sarcomatoid Renal Cell Carcinoma
5 registered clinical trials studyying Advanced Sarcomatoid Renal Cell Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy NCT07218692 | City of Hope Medical Center | Phase 2 |
| Recruiting | Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatm NCT07128680 | City of Hope Medical Center | Phase 1 |
| Recruiting | CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer NCT06399419 | Osel, Inc. | Phase 1 |
| Active Not Recruiting | CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cance NCT05122546 | City of Hope Medical Center | Phase 1 |
| Completed | Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Tr NCT01664182 | National Cancer Institute (NCI) | Phase 2 |